Clinical Neurology NewsOcrelizumab decreases relapses, brain lesion development in relapsing-remitting MSOctober 17, 2015Multiple Sclerosis
Clinical Neurology NewsObesity linked to chronic lower back and musculoskeletal painOctober 17, 2015Pain
Clinical Neurology NewsIdarucizumab approved as first agent to reverse a novel oral anticoagulantOctober 16, 2015
Clinical Neurology NewsHHS: Remaining uninsured worry about costs of coverageOctober 16, 2015Business of Medicine
Clinical Neurology NewsSurvey: Medicaid pay holds steady in statesOctober 15, 2015Business of Medicine
Clinical Neurology NewsGlutamate-based neuroimaging identifies epileptic fociOctober 15, 2015Epilepsy & Seizures
Clinical Neurology NewsHalf of uninsured patients are eligible for Medicaid or ACA coverageOctober 14, 2015Business of Medicine
Clinical Neurology NewsTCT: Routine thrombectomy with PCI raises stroke risk 66% in STEMI patientsOctober 14, 2015Stroke
Clinical Neurology NewsOcrelizumab posts first-ever positive outcome data for primary progressive MSOctober 14, 2015Multiple Sclerosis
Clinical Neurology NewsDaclizumab’s efficacy against MS tempered by adverse eventsOctober 14, 2015Multiple Sclerosis
Clinical Neurology NewsConcussionlike symptoms prevalent in uninjured teen athletesOctober 13, 2015PediatricsNeurosurgery & Trauma
Neurology ReviewsSodium Channel Blockade With Phenytoin Has a Neuroprotective Effect After Acute Optic NeuritisOctober 13, 2015Multiple Sclerosis
Neurology ReviewsAnti-JCV Antibody Index and L-Selectin Hone PML Risk Stratification During Natalizumab TherapyOctober 13, 2015Multiple Sclerosis
Neurology ReviewsCannabinoid Spray Effectively Relieves MS-Related SpasticityOctober 13, 2015Multiple Sclerosis